News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

HIE Use Rises along with Adoption of EHRs, but Full Interoperability Remains Elusive for Hospitals, Physicians, Clinical Labs, and Pathology Groups

The majority of the nation’s hospitals and physicians now use electronic health records and most of these EHR users are already exchanging clinical data with regional HIEs

Pathologists tracking the adoption of EHR systems by hospitals and physicians will be interested to learn that, according to the federal government, more than 80% of hospitals and 50% of physicians now use these products. It is also reported that growing numbers of providers are exchanging data with health information exchanges.

Clinical laboratories and anatomic pathology groups have a big stake in these developments. Medical laboratory test data is an essential component to every patient’s permanent health record, which is why it is important for every lab to have interfaces with the HIEs serving their communities and regions.
(more…)

New Study of Fruit Fly Genome Reveals Complexity of RNA and Provides a Model for Studying Mechanisms for Hereditary Diseases in Humans

This investigation of the fruit fly’s transcriptome—the complete collection of the genome’s RNA—unearthed thousands of new genes, transcripts, and proteins

Scientists have teased another level of information out of the genome. This time, the new insights were developed from studies of the fruit fly’s transcriptome. This knowledge will give pathologists another channel of information that may be useful in developing assays to support more precise diagnosis and therapeutic decisions.

The findings were published in a recent issue of Nature. The study focused on the transcriptome—a complete collection of the genome’s RNA—of the common fruit fly−Drosophila melangogaster. (more…)

Consumers May Soon Have a Home Blood Collection Kit That Allows Them to Monitor and Quantify Damage to Their DNA

Exogen uses crowdfunding to both collect needed specimens and raise capital to pursue FDA clearance for its proposed medical laboratory test that would identify an individual’s damaged DNA

It might be coming soon to a pharmacy or other retail store near you: a medical laboratory test kit allows consumers to test themselves for damaged DNA. This bold new world for genetic testing is the vision of a new company in San Francisco called Exogen Biotechnology.

This startup business was co-founded by Sylvain Costes, Ph.D., a nuclear engineer who serves as Exogen’s Chief Executive Officer, and Jonathan Tang, Ph.D., a bioengineer. Their team is developing a blood test that will enable consumers to monitor their own DNA damage and take actions to reverse the damage. (more…)

Mayo Clinic and Whole Biome Announce Collaboration to Research the Role of the Human Microbiome in Women’s Diseases Using Unique Medical Laboratory Tests

This joint research effort will initiate a new field of clinical laboratory diagnostic tests that target the human microbiome

Mayo Clinic Center for Individualized Medicine is about to commence clinical trials utilizing innovative clinical laboratory tests that target the human microbiome. Women’s health is the initial focus for these clinical studies.

Mayo Clinic is collaborating with San Francisco-based Whole Biome, Inc., to conduct these clinical trials. Whole Biome developed the diagnostic tests to be used in the clinical study. (more…)

Many Physicians Deciding not to Proceed with EHR Adoption in a Development that Could Affect Clinical Laboratories Offering LIS-to-EHR Interfaces to Doctors

One problem for physicians is that many EHR products that earned Meaningful Use Stage 1 certification have not gained Stage 2 certification

Growing numbers of physicians are deciding that continuing in the federal government’s electronic health records (EHRs) incentive program is not a winning proposition. This is not an auspicious development for the nation’s clinical laboratories and anatomic pathology groups.

After all, every medical laboratory in the United States is spending time and money to interface their laboratory information systems with physician clients’ EHR systems to enable electronic lab test ordering and reporting. Thus, if substantial numbers of physicians decide to opt out the federal EHR incentive program, this will create a variety of problems for clinical laboratories providing lab-testing services to these physicians. (more…)

Swiss Researchers Developing a Smartphone-based Coagulation Test to Help Patients on Anticoagulation Therapy to Self-Test at Home

The device would save patients frequent trips to a hospital medical laboratory and automatically transmit coag test results to attending physicians

Researchers in Switzerland are putting coagulation testing together with a smartphone specifically to allow patients to do home self-testing. This is another example of how technology is getting closer to moving medical laboratory tests out of the core lab and into near-patient settings.

This groundbreaking work is being done by researchers at École Polytechnique Fédérale de Lausanne (EPFL) [Swiss Federal Institute of Technology]. They want to develop a smartphone device that enables patients to monitor their own anticoagulation therapy at home, according to a report published by Fiercemobilehealthcare.com. (more…)

;